SK286583B6 - Použitie kyseliny tiludrónovej a jej derivátov naprípravu farmaceutických prípravkov na prevenciu a liečbu osteoporózy hydiny - Google Patents

Použitie kyseliny tiludrónovej a jej derivátov naprípravu farmaceutických prípravkov na prevenciu a liečbu osteoporózy hydiny Download PDF

Info

Publication number
SK286583B6
SK286583B6 SK55-2001A SK552001A SK286583B6 SK 286583 B6 SK286583 B6 SK 286583B6 SK 552001 A SK552001 A SK 552001A SK 286583 B6 SK286583 B6 SK 286583B6
Authority
SK
Slovakia
Prior art keywords
laying
bone
hens
use according
onset
Prior art date
Application number
SK55-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK552001A3 (en
Inventor
Thierry Bardon
Dominique Thibaud
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of SK552001A3 publication Critical patent/SK552001A3/sk
Publication of SK286583B6 publication Critical patent/SK286583B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK55-2001A 2000-01-12 2001-01-12 Použitie kyseliny tiludrónovej a jej derivátov naprípravu farmaceutických prípravkov na prevenciu a liečbu osteoporózy hydiny SK286583B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0000356A FR2803521B1 (fr) 2000-01-12 2000-01-12 Utilisation de l'acide tiludronique et de ses derives chez la volaille pour la preparation d'un medicament destine a prevenir et a traiter l'osteoporose

Publications (2)

Publication Number Publication Date
SK552001A3 SK552001A3 (en) 2001-08-06
SK286583B6 true SK286583B6 (sk) 2009-01-07

Family

ID=8845841

Family Applications (1)

Application Number Title Priority Date Filing Date
SK55-2001A SK286583B6 (sk) 2000-01-12 2001-01-12 Použitie kyseliny tiludrónovej a jej derivátov naprípravu farmaceutických prípravkov na prevenciu a liečbu osteoporózy hydiny

Country Status (15)

Country Link
US (1) US6482809B1 (de)
EP (1) EP1129714B1 (de)
JP (1) JP2001199891A (de)
AT (1) ATE306273T1 (de)
AU (1) AU783667B2 (de)
CZ (1) CZ2001135A3 (de)
DE (1) DE60113895T2 (de)
DK (1) DK1129714T3 (de)
ES (1) ES2249396T3 (de)
FR (1) FR2803521B1 (de)
HU (1) HUP0100122A3 (de)
IL (1) IL140839A0 (de)
NZ (1) NZ509285A (de)
SK (1) SK286583B6 (de)
ZA (1) ZA200100289B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301143B6 (cs) * 2005-03-10 2009-11-18 Koropecký@Igor Zpusob získávání koncentrovaného glycerolu a smesi vyšších mastných kyselin z glycerinové fáze, vznikající pri výrobe bionafty

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5953894A (en) * 1992-12-23 1994-07-19 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss
EP0950417A3 (de) * 1998-02-23 2000-02-23 Pfizer Products Inc. Behandlung von Skeletterkrankungen
CA2370769A1 (en) * 1999-04-22 2000-11-02 Hydromed Sciences A Division Of Gp Strategies Corporation Controlled delivery of bisphosphonates

Also Published As

Publication number Publication date
EP1129714B1 (de) 2005-10-12
CZ2001135A3 (cs) 2001-08-15
AU1114101A (en) 2001-07-19
AU783667B2 (en) 2005-11-24
FR2803521A1 (fr) 2001-07-13
JP2001199891A (ja) 2001-07-24
HU0100122D0 (en) 2001-03-28
IL140839A0 (en) 2002-02-10
FR2803521B1 (fr) 2002-10-25
HUP0100122A3 (en) 2003-02-28
US6482809B1 (en) 2002-11-19
EP1129714A1 (de) 2001-09-05
ATE306273T1 (de) 2005-10-15
SK552001A3 (en) 2001-08-06
ZA200100289B (en) 2001-07-24
HUP0100122A2 (hu) 2002-03-28
DE60113895D1 (de) 2006-02-23
ES2249396T3 (es) 2006-04-01
DK1129714T3 (da) 2006-02-06
NZ509285A (en) 2002-05-31
DE60113895T2 (de) 2006-06-22

Similar Documents

Publication Publication Date Title
AU686628B2 (en) Parathyroid Hormone and Raloxifene for Increasing Bone Mass
KR20060069857A (ko) N-(3-메톡시-5-메틸피라진-2-일)-2-(4-[1,3,4-옥사디아졸-2-일]페닐)피리딘-3-설폰아미드 및 lhrh 유사체및/또는 비스포스포네이트를 포함하는 조합물
PT1473040E (pt) Utilização de hormona paratiróide humana
BG108339A (bg) Лечение на деменция и дегенеративни разстройства с междинни дози lhrh-антагонисти
SK286583B6 (sk) Použitie kyseliny tiludrónovej a jej derivátov naprípravu farmaceutických prípravkov na prevenciu a liečbu osteoporózy hydiny
JPH11513383A (ja) ウマの舟状骨病を治療する方法
US6649601B2 (en) Process for increasing the egg production and strengthening the eggshells of poultry
AU1110600A (en) Methods for regulating bone formation
EP1328277B1 (de) Bisphosphonsäurederivate zur stärkung von kortikalknochen
JP2001199891A5 (de)
KR20220032874A (ko) 2,4,6-트리페닐-1-헥센을 유효성분으로 포함하는 골질환 예방 또는 치료용 조성물
CS276253B6 (cs) Léčivo hypertyreózy